Azacitidine maintenance therapy
Showing 1 - 25 of >10,000
Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- Oral azacitidine
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Acute Myeloid Leukemia Trial in Aurora (Azacitidine and Venetoclax)
Active, not recruiting
- Acute Myeloid Leukemia
- Azacitidine and Venetoclax
-
Aurora, ColoradoUniversity of Colorado Denver
Aug 1, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Baltimore (Azacitidine, Sargramostim)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Azacitidine
- Sargramostim
-
Baltimore, MarylandThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sep 23, 2022
Acute Myeloid Leukemia in Remission, FLT3 Gene Mutation, Hematologic and Lymphocytic Disorder Trial in Houston (Azacitidine,
Recruiting
- Acute Myeloid Leukemia in Remission
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Azacitidine
- +2 more
-
Suzhou, Jiangsu, China
- +1 more
Aug 18, 2022
Hypomethylating Agent, Venetoclax, Myeloid Malignancy Trial in Shanghai (Venetoclax, Azacitidine or decitabine)
Recruiting
- Hypomethylating Agent
- +2 more
- Venetoclax
- Azacitidine or decitabine
-
Shanghai, Shanghai, ChinaShanghai Jiao Tong University School of Medicine Affilated Shang
May 2, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 10, 2023
Acute Myeloid Leukemia in Remission Trial in Nanjing (Azacitidine, Lenalidomide)
Recruiting
- Acute Myeloid Leukemia in Remission
-
Nanjing, Jiangsu, ChinaDepartment of Hematology, Zhongda Hospital Southeast University,
Mar 23, 2022
Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)
Recruiting
- Leukemia, Myeloid, Acute
-
Guanzhou, Guandong, ChinaNanfang Hospital of Southern Medical University
Mar 6, 2022
Acute Myeloid Leukemia or MDS Trial in United States (APR-246)
Completed
- Acute Myeloid Leukemia or Myelodysplastic Syndromes
-
Tampa, Florida
- +6 more
Jan 18, 2022
Acute Myeloid Leukemia Trial in Japan (Oral Azacitidine, Placebo)
Recruiting
- Acute Myeloid Leukemia
- Oral Azacitidine
- Placebo
-
Nagoya, Aichi, Japan
- +30 more
May 25, 2022
Stem Cell Transplantation, Leukemia Trial in Houston (Fludarabine, Busulfan, Thymoglobulin)
Completed
- Stem Cell Transplantation
- Leukemia
- Fludarabine
- +4 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 21, 2021
Acute Myeloid Leukemia (AML) Trial in Hershey (Pevonedistat, transplant, Azacitidine)
Terminated
- Acute Myeloid Leukemia (AML)
- Pevonedistat
- +2 more
-
Hershey, PennsylvaniaPenn State Hershey Medical Center: Penn State Cancer Institute
Nov 22, 2020
MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)
Active, not recruiting
- Myelodysplastic Syndromes (MDS)
- Acute Myelogenous Leukemia (AML)
- low dose 5'-azacitidine
-
Basking Ridge, New Jersey
- +6 more
Dec 1, 2022
Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS Trial in Maywood (Vidaza and Valproic Acid)
Recruiting
- Acute Myelogenous Leukemia AML
- Myelodysplastic Syndrome MDS
- Vidaza and Valproic Acid
-
Maywood, IllinoisLoyola University Cardinal Bernardin Cancer Center
Apr 23, 2021
Solid Tumor, Gastrointestinal Cancer, Breast Cancer Trial in Singapore (QPOP, CURATE.AI, Azacitidine + docetaxel)
Not yet recruiting
- Solid Tumor
- +2 more
- QPOP
- +4 more
-
Singapore, SingaporeNational University Hospital
May 18, 2022
Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life
Recruiting
- Secondary Myelodysplastic Syndrome
- Therapy-Related Myelodysplastic Syndrome
- Azacitidine
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 1, 2022
Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)
Active, not recruiting
- Pancreas Cancer
-
New York, New YorkColumbia University Irving Medical Center
Nov 29, 2022
Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)
Recruiting
- Refractory/Relapse Acute Myeloid Leukemia
-
Kunming, Yunnan, ChinaDepartment of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- Oral azacitidine
- Matched placebo
-
Birmingham, United Kingdom
- +20 more
Oct 14, 2021
Acute Myeloid Leukemia Trial in Kunming (Venetoclax in combination with azacitidine and CAG)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax in combination with azacitidine and CAG
-
Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
Dec 20, 2022
Peripheral T Cell Lymphoma, Epigenetic Repression Trial in Tianjin (Chidamide, Azacitidine)
Recruiting
- Peripheral T Cell Lymphoma
- Epigenetic Repression
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 14, 2023